查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1356798

子宮內膜異位症市場報告：2030 年趨勢、預測與競爭分析

Endometriosis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

子宮內膜異位症趨勢與預測

預計到 2030 年，全球子宮內膜異位症市場將達到 31 億美元，2024 年至 2030 年年複合成長率為 13.1%。這個市場的主要促進因素是子宮內膜異位症研究資金的增加、感染疾病爆發和流行病的激增以及人們對子宮內膜異位症的認知不斷提高。僅此而已。全球子宮內膜異位症市場的未來前景廣闊，醫院、居家醫療和專科中心市場充滿機會。

子宮內膜異位症市場洞察

Lucintel預計，在預測期內，由於表淺腹膜病變的患病不斷上升，以及旨在提高人們對子宮內膜異位症認知的計劃以及政府對子宮內膜異位症研究的資助增加，我們預測表淺腹膜病變將呈現最高成長。

由於醫院藥局數量不斷增加，且病患對醫院優質服務和設施的偏好不斷增加，醫院可能仍是最大的細分市場。

由於子宮內膜異位症患者患病不斷上升以及該地區市場參與企業不斷增加的戰略配合措施，預計亞太地區在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2. 未來哪個細分市場成長較快？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要要素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球子宮內膜異位症市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球子宮內膜異位症市場趨勢（2018-2023）與預測（2024-2030）
  • 全球子宮內膜異位症市場（按類型）
    • 表淺腹膜病變
    • 子宮內膜異位症
    • 其他
  • 按配銷通路分類的全球子宮內膜異位症市場
    • 醫院藥房
    • 網路藥房
    • 零售藥房
  • 按治療分類的全球子宮內膜異位症市場
    • 口服避孕藥
    • 促性腺激素釋放激素 (GnRH) 藥物
    • 其他
  • 以最終用途行業分類的全球子宮內膜異位症市場
    • 醫院
    • 居家護理
    • 專業中心
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球子宮內膜異位症市場（按地區）
  • 北美子宮內膜異位症市場
  • 歐洲子宮內膜異位症市場
  • 亞太子宮內膜異位症市場
  • 其他區域子宮內膜異位症市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按類型分類的全球子宮內膜異位症市場成長機會
    • 全球子宮內膜異位症市場成長機會（按配銷通路）
    • 全球子宮內膜異位症市場的治療方法成長機會
    • 最終用途產業的全球子宮內膜異位症市場成長機會
    • 全球子宮內膜異位症市場成長機會（按地區）
  • 全球子宮內膜異位症市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球子宮內膜異位症市場的產能
    • 全球子宮內膜異位症市場的合併、收購及合資企業
    • 認證和許可

第7章 主要企業概況

  • Consilient Health
  • Sun Pharmaceutical
  • Sanofi
  • AstraZeneca
  • Serum Institute of India
  • Pfizer
  • Teva Pharmaceutical Industries
  • GlaxoSmithKline
  • Merck
  • Abbott Laboratories
簡介目錄

Endometriosis Trends and Forecast

The future of the global endometriosis market looks promising with opportunities in the hospital, homecare, and speciality center markets. The global endometriosis market is expected to reach an estimated $3.1 billion by 2030 with a CAGR of 13.1% from 2024 to 2030. The major drivers for this market are increasing funding for endometriosis research, surge in infectious disease outbreaks and pandemics is observed, and growing awareness towards endometriosis.

A more than 150-page report is developed to help in your business decisions.

Endometriosis by Segment

The study includes a forecast for the global endometriosis by type, distribution channel, treatment, end use industry, and region.

Endometriosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Superficial Peritoneal Lesion
  • Endometriomas
  • Others

Endometriosis Market by Distribution channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Endometriosis Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Oral Contraceptives
  • Gonadotropin-Releasing Hormone (GnRH) Medicines
  • Others

Endometriosis Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Homecare
  • Speciality Centers
  • Others

Endometriosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Endometriosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies endometriosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the endometriosis companies profiled in this report include-

  • Consilient Health
  • Sun Pharmaceutical
  • Sanofi
  • Astrazeneca
  • Serum Institute Of India
  • Pfizer
  • Teva Pharmaceutical Industries
  • Glaxosmithkline
  • Merck
  • Abbott Laboratories

Endometriosis Market Insights

Lucintel forecasts that superficial peritoneal lesion is expected to witness highest growth over the forecast period due to the rising prevalence of superficial peritoneal lesions, coupled with programs aimed at boosting endometriosis awareness and increased government funding for endometriosis research.

Hospitals will remain the largest segment due to the increase in the number of hospital pharmacies and growing patient preference for hospitals due to their high-quality services and facilites.

APAC is expected to witness highest growth over the forecast period due to the increasing prevalence of endometriosis cases and rising number of strategic intiatives by market players in the region.

Features of the Global Endometriosis Market

Market Size Estimates: Endometriosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Endometriosis market by various segments, such as by type, distribution channel, treatment, end use industry and region in terms of($B).

Regional Analysis: Endometriosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, distribution channels, treatments, end use industries, and region.s for the endometriosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the endometriosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the endometriosis market size?

Answer: The global endometriosis market is expected to reach an estimated $3.1 billion by 2030.

Q.2. What is the growth forecast for endometriosis market?

Answer: The global endometriosis market is expected to grow with a CAGR of 13.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the endometriosis market?

Answer: The major drivers for this market are increasing funding for endometriosis research, surge in infectious disease outbreaks and pandemics is observed, and growing awareness towards endometriosis.

Q.4. What are the major segments for endometriosis market?

Answer: The future of the endometriosis market looks promising with opportunities in the hospital, homecare, and speciality center markets.

Q.5. Who are the key Endometriosis Market companies?

Answer: Some of the key endometriosis companies are as follows:

  • Consilient Health
  • Sun Pharmaceutical
  • Sanofi
  • AstraZeneca
  • Serum Institute of India
  • Pfizer
  • Teva Pharmaceutical Industries
  • GlaxoSmithKline
  • Merck
  • Abbott Laboratories

Q.6. Which endometriosis market segment will be the largest in future?

Answer: Lucintel forecasts that superficial peritoneal lesion is expected to witness highest growth over the forecast period due to the rising prevalence of superficial peritoneal lesions, coupled with programs aimed at boosting endometriosis awareness and increased government funding for endometriosis research.

Q.7. In endometriosis market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to the increasing prevalence of endometriosis cases and rising number of strategic intiatives by market players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the endometriosis market by type (superficial peritoneal lesion, endometriomas, and others), distribution channel (hospital pharmacy, online pharmacy, and retail pharmacy), treatment (oral contraceptives, gonadotropin-releasing hormone (GnRH) medicines, and others), end use industry (hospitals, homecare, speciality centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Endometriosis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Endometriosis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Endometriosis Market by Type
    • 3.3.1: Superficial Peritoneal Lesion
    • 3.3.2: Endometriomas
    • 3.3.3: Others
  • 3.4: Global Endometriosis Market by Distribution channel
    • 3.4.1: Hospital Pharmacy
    • 3.4.2: Online Pharmacy
    • 3.4.3: Retail Pharmacy
  • 3.5: Global Endometriosis Market by Treatment
    • 3.5.1: Oral Contraceptives
    • 3.5.2: Gonadotropin-Releasing Hormone (GnRH) Medicines
    • 3.5.3: Others
  • 3.6: Global Endometriosis Market by End Use Industry
    • 3.6.1: Hospitals
    • 3.6.2: Homecare
    • 3.6.3: Speciality Centers
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Endometriosis Market by Region
  • 4.2: North American Endometriosis Market
    • 4.2.2: North American Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
  • 4.3: European Endometriosis Market
    • 4.3.1: European Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
    • 4.3.2: European Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
  • 4.4: APAC Endometriosis Market
    • 4.4.1: APAC Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
    • 4.4.2: APAC Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
  • 4.5: ROW Endometriosis Market
    • 4.5.1: ROW Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
    • 4.5.2: ROW Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Endometriosis Market by Type
    • 6.1.2: Growth Opportunities for the Global Endometriosis Market by Distribution channel
    • 6.1.3: Growth Opportunities for the Global Endometriosis Market by Treatment
    • 6.1.4: Growth Opportunities for the Global Endometriosis Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Endometriosis Market by Region
  • 6.2: Emerging Trends in the Global Endometriosis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Endometriosis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Endometriosis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Consilient Health
  • 7.2: Sun Pharmaceutical
  • 7.3: Sanofi
  • 7.4: AstraZeneca
  • 7.5: Serum Institute of India
  • 7.6: Pfizer
  • 7.7: Teva Pharmaceutical Industries
  • 7.8: GlaxoSmithKline
  • 7.9: Merck
  • 7.10: Abbott Laboratories